Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service？ Thank you for choosing ACROBiosystems. Would you rate our product and service？
Here come GMP Grade Cytokines！Free Sample is available！ Here come GMP Grade Cytokines！Free Sample is available！
| 製造番号 | 種類 | 製品説明 | 構造 | 純度 | 特徴 |
|---|---|---|---|---|---|
| CD2-H82E8 | Human | Biotinylated Human CD52 Protein, His,Avitag™ |  |
|
|
| CD2-H525a | Human | Human CD52 Protein, Fc Tag |  |
|
|
| CD2-H82F3 | Human | Biotinylated Human CD52 Protein, Fc,Avitag™ |  |
|
Anti-Human CD52 MAb (Human IgG1) captured on CM5 chip via anti-human IgG Fc antibodies surface can bind Biotinylated Human CD52, His,Avitag (Cat. No. CD2-H82E8) with an affinity constant of 71.8 nM as determined in a SPR assay (Biacore T200) (Routinely tested).
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Alemtuzumab | LDP-03; GZ-402673 | Approved | Genzyme Corp, Bayer AG | Campath, Lemtrada, MabCampath | Japan | Leukemia, Lymphocytic, Chronic, B-Cell | Sanofi | 2001-05-07 | Myositis, Inclusion Body; Mycosis Fungoides; Leukemia, Lymphocytic, Chronic, B-Cell; Fallopian Tube Neoplasms; Lymphoma, T-Cell, Cutaneous; Lymphoma, T-Cell; Leukemia, Prolymphocytic, T-Cell; Lymphoma, Non-Hodgkin; Lymphoma; Waldenstrom Macroglobulinemia; Leukemia, Myeloid, Acute; Sezary Syndrome; Lymphoproliferative Disorders; Peritoneal Neoplasms; Pancytopenia; Diabetes Mellitus, Type 1; Rejection of organ transplantation; Multiple Sclerosis; Myelodysplastic Syndromes; Leukemia-Lymphoma, Adult T-Cell; Kidney Diseases; Graft vs Host Disease; Ovarian Neoplasms; Bone marrow transplant rejection; Lymphoma, T-Cell, Peripheral; Hematologic Neoplasms; Multiple Sclerosis, Relapsing-Remitting; Rejection of renal transplantation; Leukemia | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Alemtuzumab biosimilar (Zhangjiang Biotechnology) | Phase 2 Clinical | Shanghai Zhangjiang Biotechnology Co Ltd | Leukemia, Lymphocytic, Chronic, B-Cell | Details | |
| Alemtuzumab biosimilar(BioXpress) | BX-1523; BXT-1523 | Clinical | Bioxpress Therapeutics Sa | Multiple Sclerosis; Leukemia, B-Cell | Details |
| Recombinant anti-CD52 humanized monoclonal antibody (Lanzhou Institute Of Biological Products/Shanghai Taiyin Biotechnology) | Phase 1 Clinical | Lanzhou Institute Of Biological Products Co Ltd, Shanghai Taiyin Biotechnology Co Ltd | Leukemia, B-Cell; Leukemia, Prolymphocytic, T-Cell; Lymphoma; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Prolymphocytic | Details | |
| ALLO-647 | ALLO-647 | Phase 2 Clinical | Allogene Therapeutics Inc | Lymphoma, B-Cell; Carcinoma, Renal Cell; Multiple Myeloma; Lymphoma, Follicular | Details |
This web search service is supported by Google Inc.
アクロバイオシステムズの公式アカウント
A-Z
